Leaderboards/Pregnancy and preeclampsia studies

Pregnancy and preeclampsia studies

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Christopher R. McCartney
West Virginia University
99
2
Durairaj Sekar
Saveetha University
78
3
Morten Rasmussen
University of California System
70
4
Torbjörn Tomson
Karolinska University Hospital
67
5
Lingling Jiang
Sir Run Run Shaw Hospital
62
6
John‏ Kingdom
University of Toronto
61
7
Amy Metcalfe
University of Calgary
58
8
Sarosh Rana
University of Chicago Medical Center
57
9
Peter G. J. Nikkels
Utrecht University
56
10
Farideh Montazeri
Hormozgan University of Medical Sciences
56

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Ying‐Ling Yao
Changsha Medical University
99
2
Casey Crump
The University of Texas Health Science Center at Houston
96
3
Adriana Alejandra Márquez Ibarra
Sonora Institute of Technology
96
4
Sofie Taageby Nielsen
Copenhagen University Hospital
69
5
Nazanin Rezaei
Hormozgan University of Medical Sciences
63
6
Fikriye Karanfil Yaman
Necmettin Erbakan University
63
7
Stephanie A. Leonard
Stanford Medicine
63
8
Samuel Hofbauer
Rowan University
63
9
Ernesto Antônio Figueiró-Filho
Regina General Hospital
63
10
A. Gabet
Twitter (United States)
63

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Moshe Hod
Tel Aviv University
96
2
Stefan Verlohren
Charité - Universitätsmedizin Berlin
91
3
Phyllis August
American Heart Association
91
4
Heather S. Lipkind
Unknown
86
5
K. H. Nicolaides
King's College London
82
6
S. Ananth Karumanchi
Hadassah Medical Center
76
7
Garland Anderson
The University of Texas Medical Branch at Galveston
69
8
Jeremy Oats
The University of Queensland
67
9
K.S. Joseph
University of British Columbia
65
10
Vincent W. V. Jaddoe
Erasmus MC
61

All-Time Leaders Papers

1
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
Journal of Clinical Investigation|2003
4k cit.
2
Preeclampsia
Circulation Research|2019
2k cit.
3
The Generation R Study: design and cohort update 2017
European Journal of Epidemiology|2016
1.2k cit.
4
The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care<sup>#</sup>
International Journal of Gynecology & Obstetrics|2015
774 cit.
5
FIGO (International Federation of Gynecology and Obstetrics) initiative on fetal growth: Best practice advice for screening, diagnosis, and management of fetal growth restriction
International Journal of Gynecology & Obstetrics|2021
534 cit.
6
ASPRE trial: performance of screening for preterm pre‐eclampsia
Ultrasound in Obstetrics and Gynecology|2017
455 cit.
7
Global interim guidance on coronavirus disease 2019 (COVID‐19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals
International Journal of Gynecology & Obstetrics|2020
313 cit.
8
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
American Journal of Obstetrics and Gynecology|2020
310 cit.
9
Soluble fms-like tyrosine kinase 1 promotes angiotensin II sensitivity in preeclampsia
Journal of Clinical Investigation|2016
153 cit.
10
Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms–like tyrosine kinase 1 pathway
Journal of Clinical Investigation|2022
27 cit.

Indexing Pregnancy and preeclampsia studies Reagents

Citation data for reagents in this field is currently compiling.